Skip to content

HR 10887 · United States Congress · 119 · Billy

Skip to content

Home
/
Bills
/
United States Congress
/
119
/
HR 10887

United States Congress · 119 session · house

HR 10887Protecting Consumer Access to Generic Drugs Act of 2026

Status: In committee
Latest action: 2026-10-22 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Primary sponsor: Rep. Magaziner, Seth [D-RI-2] (D)

Health

Track this bill

Sponsors

Rep. Magaziner, Seth [D-RI-2] (D) · sponsorprimary

Versions

Introduced in HouseOct 22, 2026

Legislative history

Public legislative record via Billy. Sign in to track, annotate, and export work product.

About public bill pages Compare Billy United States Congress bill RSS

Oct 22, 2026
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 22, 2026
Introduced in House
Oct 22, 2026
Introduced in House
Oct 22, 2026
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Official sources

Version 0PDF HTML XML

About this page

Is this the official United States Congress bill page?: No — this is Billy’s public legislative record for HR 10887. Official source links are listed above when publishers provide them.
Can I track updates?: Yes. Sign in to track HR 10887, get alerts, annotate diffs, and export Word work product.